Literature DB >> 22752277

Transanal rectosigmoid resection via natural orifice translumenal endoscopic surgery (NOTES) with total mesorectal excision in a large human cadaver series.

Dana A Telem1, Kyung Su Han, Min-Chan Kim, Ifode Ajari, Dae Kyung Sohn, Kevin Woods, Varun Kapur, Mohammad A Sbeih, Silvana Perretta, David W Rattner, Patricia Sylla.   

Abstract

BACKGROUND: The authors' group has previously described successful transanal rectosigmoid resection via natural orifice translumenal endoscopic surgery (NOTES) in both porcine and cadaveric models using the transanal endoscopic microsurgery platform. This report describes the largest cadaveric series to date as optimization of this approach for clinical application continues.
METHODS: Between December 2008 and September 2011, NOTES transanal rectosigmoid resection with total mesorectal excision (TME) was successfully performed in 32 fresh human cadavers using transanal dissection alone (n = 19), with transgastric endoscopic assistance (n = 5), or with laparoscopic assistance (n = 8). The variables recorded were gender, body mass index (BMI), operative time, length of the mobilized specimen, integrity of the mesorectum and the resected specimen, and complications. Univariate statistical analysis was performed.
RESULTS: Of the 32 cadavers, 22 were male with a mean BMI of 24 kg/m(2) (range 16.3-37 kg/m(2)). The mean operative time was 5.1 h (range 3-8 h), and the mean specimen length was 53 cm (range 15-91.5 cm). After the first five cadavers, specimen length significantly improved, and a trend toward decreased operative time was demonstrated. The mesorectum was intact in 100% of the specimens. In nine cadavers, endoscopic dissection was complicated by organ injury. Evaluation by the operative approach demonstrated a significantly longer specimen with laparoscopic assistance (67.7 cm) than with transgastric assistance (45.4 cm) or transanal dissection alone (49.2 cm) (p = 0.013). Comparison of the technique used for inferior mesenteric pedicle division demonstrated both significantly decreased operative time (4.8 vs 6 h; p = 0.024) and increased specimen length (57.7 vs 39.6 cm; p = 0.025) when a stapler was used in lieu of a bipolar cautery device.
CONCLUSION: Transanal NOTES rectosigmoid resection with TME is feasible and demonstrates improvement in specimen length and operative time with experience. Transitioning to clinical application requires laparoscopic assistance to overcome limitations related to NOTES instrumentation, as well as procedural training with fresh human cadavers.

Entities:  

Mesh:

Year:  2012        PMID: 22752277     DOI: 10.1007/s00464-012-2409-y

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  14 in total

1.  Transrectal natural orifice translumenal endoscopic surgery (NOTES) for colorectal resection.

Authors:  E Rieder; M H Whiteford
Journal:  Colorectal Dis       Date:  2011-11       Impact factor: 3.788

2.  ASGE/SAGES Working Group on Natural Orifice Translumenal Endoscopic Surgery. October 2005.

Authors:  D Rattner; A Kalloo
Journal:  Surg Endosc       Date:  2006-02       Impact factor: 4.584

3.  NOTES rectosigmoid resection using transanal endoscopic microsurgery (TEM) with transgastric endoscopic assistance: a pilot study in swine.

Authors:  Patricia Sylla; Field F Willingham; Dae K Sohn; Denise Gee; William R Brugge; David W Rattner
Journal:  J Gastrointest Surg       Date:  2008-08-13       Impact factor: 3.452

4.  Transanal endoscopic microsurgical platform for natural orifice surgery.

Authors:  Peter M Denk; Lee L Swanström; Mark H Whiteford
Journal:  Gastrointest Endosc       Date:  2008-11       Impact factor: 9.427

5.  Transmediastinal endoscopic intervention.

Authors:  Denise W Gee; David W Rattner
Journal:  J Gastrointest Surg       Date:  2011-06-14       Impact factor: 3.452

6.  The Second SAGES/ASGE White Paper on natural orifice transluminal endoscopic surgery: 5 years of progress.

Authors:  David W Rattner; Robert Hawes; Steven Schwaitzberg; Michael Kochman; Lee Swanstrom
Journal:  Surg Endosc       Date:  2011-02-27       Impact factor: 4.584

7.  Survival study of natural orifice translumenal endoscopic surgery for rectosigmoid resection using transanal endoscopic microsurgery with or without transgastric endoscopic assistance in a swine model.

Authors:  Patricia Sylla; Dae Kyung Sohn; Sevdenur Cizginer; Yusuf Konuk; Brian G Turner; Denise W Gee; Field F Willingham; Maylee Hsu; Mari Mino-Kenudson; William R Brugge; David W Rattner
Journal:  Surg Endosc       Date:  2010-02-21       Impact factor: 4.584

8.  NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance.

Authors:  Patricia Sylla; David W Rattner; Salvadora Delgado; Antonio M Lacy
Journal:  Surg Endosc       Date:  2010-02-26       Impact factor: 4.584

9.  Scarless cholecystectomy with combined transvaginal and transumbilical approach in a series of 20 patients.

Authors:  C Zornig; H Mofid; A Emmermann; M Alm; H-A von Waldenfels; C Felixmüller
Journal:  Surg Endosc       Date:  2008-04-09       Impact factor: 4.584

10.  Feasibility of radical sigmoid colectomy performed as natural orifice translumenal endoscopic surgery (NOTES) using transanal endoscopic microsurgery.

Authors:  M H Whiteford; P M Denk; L L Swanström
Journal:  Surg Endosc       Date:  2007-08-21       Impact factor: 3.453

View more
  28 in total

Review 1.  Shifting Paradigms in Minimally Invasive Surgery: Applications of Transanal Natural Orifice Transluminal Endoscopic Surgery in Colorectal Surgery.

Authors:  Grace Clara Lee; Patricia Sylla
Journal:  Clin Colon Rectal Surg       Date:  2015-09

2.  Transanal total mesorectal excision (taTME) for rectal cancer: a training pathway.

Authors:  Elisabeth C McLemore; Christina R Harnsberger; Ryan C Broderick; Hyuma Leland; Patricia Sylla; Alisa M Coker; Hans F Fuchs; Garth R Jacobsen; Bryan Sandler; Vikram Attaluri; Anna T Tsay; Steven D Wexner; Mark A Talamini; Santiago Horgan
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

3.  Transanal total mesorectal excision: the Slagelse experience 2013-2019.

Authors:  Sharaf Karim Perdawood; Jens Kroeigaard; Marianne Eriksen; Pauli Mortensen
Journal:  Surg Endosc       Date:  2020-02-18       Impact factor: 4.584

Review 4.  Current status of laparoscopy for the treatment of rectal cancer.

Authors:  Noam Shussman; Steven D Wexner
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

Review 5.  Evolution and future of laparoscopic colorectal surgery.

Authors:  Andreas M Kaiser
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

6.  Initial experience of transanal total mesorectal excision with rigid or flexible transanal platforms in cadavers.

Authors:  Min Jung Kim; Ji Won Park; Heon-Kyun Ha; Byeong Geon Jeon; Rumi Shin; Seung-Bum Ryoo; Sang-ji Choi; Byung Kwan Park; Kyu Joo Park; Seung-Yong Jeong
Journal:  Surg Endosc       Date:  2015-07-14       Impact factor: 4.584

7.  Feasibility of transanal total mesorectal excision (taTME) using the Medrobotics Flex® System.

Authors:  Heather Carmichael; Anthony P D'Andrea; Matthew Skancke; Vincent Obias; Patricia Sylla
Journal:  Surg Endosc       Date:  2019-07-26       Impact factor: 4.584

8.  Transanal minimally invasive surgery (TAMIS): applications beyond local excision.

Authors:  S Atallah; M Albert; T Debeche-Adams; S Larach
Journal:  Tech Coloproctol       Date:  2012-12-04       Impact factor: 3.781

9.  Transvaginal pure NOTES sigmoid resection using a single port device.

Authors:  M D'Hondt; D Devriendt; F Van Rooy; F Vansteenkiste; E Dozois
Journal:  Tech Coloproctol       Date:  2013-04-06       Impact factor: 3.781

10.  TAMIS-assisted laparoscopic low anterior resection with total mesorectal excision in a cadaveric series.

Authors:  Elisabeth C McLemore; Alisa M Coker; Bikash Devaraj; Jeffrey Chakedis; Ali Maawy; Tazo Inui; Mark A Talamini; Santiago Horgan; Michael R Peterson; Patricia Sylla; Sonia Ramamoorthy
Journal:  Surg Endosc       Date:  2013-03-14       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.